IP Library Granted Patent US 8,712,491
Granted Patent B2
US 8,712,491 · App. 13/542,125 · Granted Apr 29, 2014

Measurement of an analyte on the skin using a hue angle

Inventor: Michael J. Evelegh (Dundas, CA)
Assignee: Miraculins Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,712,491
App. No.
13/542,125
Granted
Apr 29, 2014
Kind
B2
Abstract

A process is provided for analyzing a skin in any of a number of biochemical or immunological tests for an analyte which involves applying to a skin surface on a patient a reagent which selectively binds to the analyte to form an analyte-reagent complex; subjecting the skin surface on the patient to a treatment which develops a color correlating to an amount of analyte in the specimen; measuring a hue angle of the color developed on the skin surface of the patient by measuring a reflectance over a range of visible light spectrum at a plurality of intervals in wavelength of the visible light spectrum to obtain a measurement; and correlating the measurement of the hue angle to determine a concentration of the analyte.

Claims (11)

1. A process of analyzing a skin for an analyte comprising the steps of:

applying to a skin surface on a patient a reagent which selectively binds to the analyte to form an analyte-reagent complex;

subjecting the skin surface on the patient to a treatment which develops a color on the skin surface of the patient correlating to an amount of the analyte;

measuring a hue angle of the color developed on the patient by measuring a reflectance over a range of a visible light spectrum at a plurality of intervals in wavelength of the visible light spectrum to obtain a measurement; and

correlating the measurement of the hue angle to determine a concentration of the analyte.

2. The process according to claim 1 wherein the reagent is a biochemical or an immunological reagent.

3. The process according to claim 1 wherein the reagent which selectively binds to the analyte is selected from the group consisting of a hydrophobic protein, a protein toxin, an antibody, and an enzyme whose substrate is the analyte.

4. The process as claimed in claim 1 , further comprising treating the reagent on the skin surface with a visualizing agent.

5. The process as claimed in claim 4 , further comprising treating the reagent on the skin surface with an indicating agent.

6. The process according to claim 1 , wherein the visible light spectrum has a range of about 400-700 nm.

7. The process according to claim 1 , wherein the intervals are each about 20 nm.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2012
From: PREMD INC.
To: MIRACULINS INC.
Reel/Frame 028945/0555 →
CHANGE OF NAME Recorded Sep 11, 2012
From: IMI INTERNATIONAL MEDICAL INNOVATIONS INC.
To: PREMD INC.
Reel/Frame 028935/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2012
From: EVELEGH, MICHAEL J.
To: IMI INTERNATIONAL MEDICAL INNOVATIONS INC.
Reel/Frame 028599/0306 →
Priority Claims (3)
CA 2279793 · Aug 6, 1999 · national
CA 2296163 · Jan 17, 2000 · national
CA 2306315 · Apr 20, 2000 · national
Continuity (3)
Continuation 10887737 · Jul 9, 2004
Continuation 09830708 · Apr 30, 2001
Related Publication 20120277553A1 · Nov 1, 2012